Results 301 to 310 of about 2,349,142 (333)
Some of the next articles are maybe not open access.
Human vascular vasopressin receptors: analysis with selective vasopressin receptor antagonists.
The Journal of Pharmacology and Experimental Therapeutics, 1986The vascular activity of arginine vasopressin (AVP) and selective AVP receptor antagonists was investigated in isolated arterial ring segments from human superior mesenteric arteries. AVP elicited a potent and concentration-dependent contraction in human mesenteric arterial rings with an EC50 value of 2.01 X 10(-9) M.
E H, Ohlstein, B A, Berkowitz
openaire +2 more sources
Receptors | Vasopressin/Oxytocin Receptor Family
Encyclopedia of Biological Chemistry III, 2021M. Brownstein, Vivian Kitainda
semanticscholar +1 more source
Arrestin Effects on Internalization of Vasopressin Receptors
Molecular Pharmacology, 2001Arrestins have been shown to facilitate the recruitment of G protein-coupled receptors to the clathrin-coated vesicles that mediate their internalization. After (8)Arg-vasopressin-induced internalization, the human V2 vasopressin receptor failed to recycle to the cell surface, whereas the vasopressin type 1a receptor (V1a) subtype did.
D. Bowen Pidgeon +3 more
openaire +4 more sources
Neuroendocrinology, 1986
We readdressed the question of whether or not rat adenohypophyseal vasopressin receptors have a ligand selectivity which is similar to that of the V1 subtype of vasopressin receptors. Vasopressin analogues substituted in positions 7 and 1 were used.
W. Knepel, D. Götz, F. Fahrenholz
semanticscholar +1 more source
We readdressed the question of whether or not rat adenohypophyseal vasopressin receptors have a ligand selectivity which is similar to that of the V1 subtype of vasopressin receptors. Vasopressin analogues substituted in positions 7 and 1 were used.
W. Knepel, D. Götz, F. Fahrenholz
semanticscholar +1 more source
Vasopressin and oxytocin receptors in the central nervous system.
Critical Reviews in Neurobiology, 1996This review concentrates on the pharmacological properties and the regional distribution of the arginine vasopressin (AVP) and oxytocin (OT) receptors that are present in the central nervous system.
Claude Barberis, E. Tribollet
semanticscholar +1 more source
2009
This chapter focuses on the expression and functions of arginine vasopressin receptors (AVPRs) throughout the body, but particularly in the brain. In order to place receptor activity into a physiologically and behaviorally relevant context, it begins with a brief overview of the hormones arginine vasopressin (AVP) and oxytocin (OT), which serve as ...
openaire +2 more sources
This chapter focuses on the expression and functions of arginine vasopressin receptors (AVPRs) throughout the body, but particularly in the brain. In order to place receptor activity into a physiologically and behaviorally relevant context, it begins with a brief overview of the hormones arginine vasopressin (AVP) and oxytocin (OT), which serve as ...
openaire +2 more sources
Chronic Blockade of Vasopressin Receptors in Rats
Journal of Cardiovascular Pharmacology, 1986Chronic i.v. administration of a competitive antagonist of arginine-vasopressin (AVP), d(CH2)5-D-Tyr(Et)-VAVP, in Sprague-Dawley rats induced only a transient diabetes insipidus (DI)-like state. Water excretion and intake were markedly increased on the first day of administration but subsequently reverted to normal. A similar response to the antagonist
Hofbauer, K. G. +2 more
openaire +3 more sources
Upregulation of V1a vasopressin receptors by glucocorticoids
American Journal of Physiology-Endocrinology and Metabolism, 1992WRK1 cells (a rat mammary tumor cell line) exhibit a vasopressinergic receptor of V1a subtype tightly coupled to phospholipase C. Addition of dexamethasone to the culture medium principally potentiated the vasopressin-sensitive accumulation of inositol phosphates and to a lesser extent the NaF-sensitive phospholipase C activity.
A. Duvoid +5 more
openaire +3 more sources
Molecular Modeling of Interaction of the Vasopressin Analogs with Vasopressin and Oxytocin Receptors
QSAR & Combinatorial Science, 2003AbstractIn this study the interaction of seven new analogs of arginine vasopressin (AVP) substituted in position 2 or 3 with 1‐aminocyclohexanecarboxylic acid (Acc) with the vasopressin (VP) and oxytocin (OT) receptors (V1aR, V2R and OTR) is described. All peptides were synthesized and tested in bioassays for pressor and antidiuretic activities.
Rajmund Kaźmierkiewicz +3 more
openaire +2 more sources
Vasopressin antagonists block peripheral as well as central vasopressin receptors
Pharmacology Biochemistry and Behavior, 1984The aim of the present study was to differentiate between the postulated central behavioral effects of vasopressin and its pressor response, which is mainly mediated by peripheral vascular receptors. Thus, the interaction between the vasopressor antagonists dPTyr(Me)AVP (AAVPa) and d(CH2)5Tyr(Me)AVP (AAVPb) with the effects of [Arg8]vasopressin (AVP-(1-
David de Wied +3 more
openaire +3 more sources